Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachael Sumner

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 19, 2026
LSD microdosing for major depressive disorder: Mood and pharmacokinetic outcomes from a phase 2a trialDimitri Daldegan-Bueno, Carina Joy Donegan, Rachael Sumner, et al.
Pilot and Feasibility Studies|October 5, 2023
An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1)Carina Joy Donegan, Dimitri Daldegan-Bueno, Rachael Sumner, et al.
Molecular Psychiatry|September 7, 2022
International pooled patient-level meta-analysis of ketamine infusion for depression: In search of clinical moderatorsRebecca B Price, Nicholas Kissel, Andrew Baumeister, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 19, 2026
LSD microdosing for major depressive disorder: Mood and pharmacokinetic outcomes from a phase 2a trialDimitri Daldegan-Bueno, Carina Joy Donegan, Rachael Sumner, et al.
Pilot and Feasibility Studies|October 5, 2023
An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1)Carina Joy Donegan, Dimitri Daldegan-Bueno, Rachael Sumner, et al.
Molecular Psychiatry|September 7, 2022
International pooled patient-level meta-analysis of ketamine infusion for depression: In search of clinical moderatorsRebecca B Price, Nicholas Kissel, Andrew Baumeister, et al.
Pageof 2